Sympathetic mediation of peripheral vasodilation induced by spinal cord stimulation: animal studies of the role of cholinergic and adrenergic receptor subtypes.

Electric spinal cord stimulation (SCS) is widely used as a treatment modality for ischemic pain in peripheral arterial insufficiency. The background for the therapeutic effect may be a temporary inhibition of sympathetically maintained peripheral vasoconstriction. In this series of experiments, the involvement of different types of cholinergic and adrenergic receptor subclasses in the vasodilatory effect was explored in anesthetized rats. The microcirculation in hindlimb skin and hamstring muscle was studied by the laser Doppler technique. The ganglionic blocker hexamethonium as well as the nicotinic receptor antagonist chlorisondamine abolished the effect in both vascular beds, whereas the muscarinic receptor antagonists pirenzepine and atropine were ineffective. Among the adrenergic receptor active compounds, phentolamine, prazosine (an alpha 1-receptor antagonist), and clonidine in high doses suppressed the SCS-induced vasodilation. Yohimbine (an alpha 2-receptor antagonist) did not alter the effect. The beta-adrenergic compounds had a differential effect on muscle and skin perfusion. Atenolol, a beta 1-receptor antagonist, inhibited SCS-induced vasodilation only in the skin, whereas the beta 2-receptor antagonist butoxamine selectively depressed the muscle response. The vasodilatory effect of SCS in the animal model used here seems to a large extent to be mediated by an inhibitory effect on peripheral vasoconstriction maintained via efferent sympathetic activity involving nicotinic transmission in the ganglia and the postganglionic alpha 1-adrenoreceptors. The involvement of beta-receptors seems to be different in skin and muscle, beta 1 being more important for the changes in the skin and beta 2 being more important for those in muscle. The high-intensity antidromic response, earlier believed to explain how SCS exerted its vasodilatory effect, was resistant to cholinergic and adrenergic manipulations and seems to depend on entirely different mechanisms.

[1]  M. Mayes,et al.  Induction of vasospastic attacks despite digital nerve block in Raynaud's disease and phenomenon. , 1989, Circulation.

[2]  D. Slaaf,et al.  Foot salvage and improvement of microvascular blood flow as a result of epidural spinal cord electrical stimulation. , 1990, Journal of vascular surgery.

[3]  Langer Sz,et al.  Alpha-adrenoreceptor subtypes in blood vessels: physiology and pharmacology. , 1984 .

[4]  H. Schoemaker,et al.  Alpha-adrenoceptor subtypes in blood vessels: physiology and pharmacology. , 1989, Clinical and experimental hypertension. Part A, Theory and practice.

[5]  C A Carlsson,et al.  Epidural Electrical Stimulation in Severe Limb Ischemia: Pain Relief, Increased Blood Flow, and a Possible Limb‐saving Effect , 1985, Annals of surgery.

[6]  S M Hilton,et al.  Dorsal root vasodilatation in cat skeletal muscle. , 1980, The Journal of physiology.

[7]  R. Willette,et al.  Sympathetic regulation of cutaneous circulation in the rat. , 1991, Journal of the autonomic nervous system.

[8]  R. Maxwell,et al.  Ganglionic blockade by a new bisquaternary series, including chlorisondamine dimethochloride. , 1955, The Journal of pharmacology and experimental therapeutics.

[9]  J. Cooke,et al.  Human postjunctional alpha-1 and alpha-2 adrenoceptors: differential distribution in arteries of the limbs. , 1987, The Journal of pharmacology and experimental therapeutics.

[10]  W. Bayliss.  On the origin from the spinal cord of the vaso‐dilator fibres of the hind‐limb, and on the nature of these fibres 1 , 1901, The Journal of physiology.

[11]  B. Meyerson,et al.  Effects of sympathectomy on skin and muscle microcirculation during dorsal column stimulation: animal studies. , 1991, Neurosurgery.

[12]  F. Mitchelson,et al.  Muscarinic receptor differentiation. , 1988, Pharmacology & therapeutics.

[13]  M. Mayes,et al.  Increased α‐Adrenergic responsiveness in idiopathic raynaud's disease , 1989 .

[14]  G. Broggi,et al.  Spinal cord stimulation for treatment of peripheral vascular disease. , 1987, Applied neurophysiology.

[15]  O. Foerster.  THE DERMATOMES IN MAN , 1933 .

[16]  A. Cook,et al.  Vascular disease of extremities. Electric stimulation of spinal cord and posterior roots. , 1976, New York state journal of medicine.

[17]  W. Stigelman,et al.  Goodman and Gilman's the Pharmacological Basis of Therapeutics , 1986 .

[18]  J. González-Darder,et al.  Spinal cord stimulation in peripheral arterial disease. A cooperative study. , 1986, Journal of neurosurgery.

[19]  R. Zimlichman,,et al.  Indices of sympathetic vascular innervation in sympathectomized patients. , 1986, Journal of the autonomic nervous system.

[20]  B. Meyerson,et al.  Peripheral vasodilatation after spinal cord stimulation: animal studies of putative effector mechanisms. , 1991, Neurosurgery.

[21]  D. Slaaf,et al.  Epidural Spinal Cord Electrical Stimulation Improves Microvascular Blood Flow in Severe Limb Ischemia , 1988, Annals of surgery.

[22]  Roger L. Black,et al.  Goodman and Gilman's The Pharmacological Basis of Therapeutics , 1991 .

[23]  J. McWilliam,et al.  Central adrenergic receptors , 1987, Journal of psychopharmacology.

[24]  J. Cabot.  Sympathetic preganglionic neurons : cytoarchitecture, ultrastructure and biophysical properties , 1990 .

[25]  M. Meglio,et al.  Spinal cord stimulation affects the central mechanisms of regulation of heart rate. , 1986, Applied neurophysiology.

[26]  R. Hammer,et al.  Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization. , 1982, Life sciences.